找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Erythrocytes as Drug Carriers in Medicine; Ulrich Sprandel,James L. Way Book 1997 Springer Science+Business Media New York 1997 blood.clin

[復(fù)制鏈接]
查看: 34611|回復(fù): 58
樓主
發(fā)表于 2025-3-21 18:26:56 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Erythrocytes as Drug Carriers in Medicine
編輯Ulrich Sprandel,James L. Way
視頻videohttp://file.papertrans.cn/316/315090/315090.mp4
圖書封面Titlebook: Erythrocytes as Drug Carriers in Medicine;  Ulrich Sprandel,James L. Way Book 1997 Springer Science+Business Media New York 1997 blood.clin
描述The sixth meeting on the use of resealed annealed red blood cells was held in Irsee, Germany by the International Society for the Use of Resealed Erythrocytes (ISURE) on July 25-28, 1996. Although earlier meetings focused on the technology toward develop- ment of methods and standardization for efficient, consistent encapsulation, most of the present studies now are directed toward the application use of these carrier blood cells. Basic studies now have been directed toward exploration of commercial applications. In- deed, clinical trials were initiated to evaluate the dose-response curves employing L- asparagenase in human patients. Also, studies have shown the use of thrombolytic agent in erythrocyte carriers with the use of human red blood cells to provide a new conceptual ap- proach in thrombolytic therapy to prevent thrombosis in individuals with higher risk fac- tors. For example, with the use of carrier red blood cells, the thrombolytic agents will have a greater potential of acting on clot formation without systemic activation and thus lower the risk of hemorrhage, which is always prevalent in the thrombolytic therapy.
出版日期Book 1997
關(guān)鍵詞blood; clinical trial; drug; immunotherapy; research; thrombosis
版次1
doihttps://doi.org/10.1007/978-1-4899-0044-9
isbn_softcover978-1-4899-0046-3
isbn_ebook978-1-4899-0044-9
copyrightSpringer Science+Business Media New York 1997
The information of publication is updating

書目名稱Erythrocytes as Drug Carriers in Medicine影響因子(影響力)




書目名稱Erythrocytes as Drug Carriers in Medicine影響因子(影響力)學(xué)科排名




書目名稱Erythrocytes as Drug Carriers in Medicine網(wǎng)絡(luò)公開度




書目名稱Erythrocytes as Drug Carriers in Medicine網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Erythrocytes as Drug Carriers in Medicine被引頻次




書目名稱Erythrocytes as Drug Carriers in Medicine被引頻次學(xué)科排名




書目名稱Erythrocytes as Drug Carriers in Medicine年度引用




書目名稱Erythrocytes as Drug Carriers in Medicine年度引用學(xué)科排名




書目名稱Erythrocytes as Drug Carriers in Medicine讀者反饋




書目名稱Erythrocytes as Drug Carriers in Medicine讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:30:44 | 只看該作者
,Quarterly Forecast for 2019–2020,e phosphorylation depends on specific cellular kinases whose levels in turn depend on the activation state of the target cells and on the cell types (5). Usually, quiescent cells have low levels of the enzymes responsible for nucleoside analogue phosphorylation, while activation (e.g., mitogen stimu
板凳
發(fā)表于 2025-3-22 00:59:58 | 只看該作者
Lorenzo Riccardi,Giorgio Riccardiion. Unfortunately, the efficacy of drugs so far used in monotherapy is of limited duration while a number of preliminary studies have already shown that combination therapy is more effective than monotherapy (8, 9). Combination therapy may provide additive or synergistic effect of combined drugs, d
地板
發(fā)表于 2025-3-22 06:32:42 | 只看該作者
5#
發(fā)表于 2025-3-22 09:25:49 | 只看該作者
https://doi.org/10.1007/978-981-13-2727-8on the action of crosslinking reagents which react with band 3 in mouse erythrocyte membrane. Additionally, biotinylation of mouse erythrocytes has been studied. “.” behaviour of these chemically modified erythrocytes have been studied. These survival results have been compared to recognition by mac
6#
發(fā)表于 2025-3-22 15:52:23 | 只看該作者
Erythrocyte-Based Targeted Release to Macrophages of an Azidothymidine Homodinucleotide Prevents Reion was observed with human, feline and murine macrophages against infection by HIV-1, FIV and LP-BM5 retroviral strains, respectively. These data demonstrate that AZT.AZT-loaded and opsonized erythrocytes represent an efficient “trojan horse” resulting in significant protection of macrophages from
7#
發(fā)表于 2025-3-22 19:14:05 | 只看該作者
Macrophage Protection by Nucleoside and Nucleotide Analogue Administration,e phosphorylation depends on specific cellular kinases whose levels in turn depend on the activation state of the target cells and on the cell types (5). Usually, quiescent cells have low levels of the enzymes responsible for nucleoside analogue phosphorylation, while activation (e.g., mitogen stimu
8#
發(fā)表于 2025-3-22 21:28:08 | 只看該作者
Inhibition of Murine AIDS by Combination of AZT and DDCTP-Loaded Erythrocytes,ion. Unfortunately, the efficacy of drugs so far used in monotherapy is of limited duration while a number of preliminary studies have already shown that combination therapy is more effective than monotherapy (8, 9). Combination therapy may provide additive or synergistic effect of combined drugs, d
9#
發(fā)表于 2025-3-23 04:23:03 | 只看該作者
10#
發(fā)表于 2025-3-23 09:28:32 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-23 21:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
如东县| 金阳县| 周口市| 贵德县| 丹阳市| 永泰县| 万宁市| 三原县| 甘孜| 大洼县| 清远市| 淳化县| 定结县| 亚东县| 高要市| 阳东县| 扬中市| 阳高县| 乌审旗| 桦川县| 秀山| 甘泉县| 巴塘县| 全南县| 红桥区| 呼伦贝尔市| 清水河县| 卓资县| 巨野县| 喀喇| 都安| 潜江市| 黑山县| 麟游县| 建平县| 汝州市| 常宁市| 南雄市| 抚宁县| 辽源市| 枣阳市|